Downloads provided by UsageCounts
pmid: 35922517
pmc: PMC9352569
handle: 2117/371635 , 11588/913567 , 1871.1/2b8b46b3-6364-409e-a505-0f32f0f4169b , 11370/00125da7-04c5-43a5-89fb-12f7d70d782f , 2268/294295 , 11365/1220799 , 10807/234173 , 20.500.11820/035ea0f3-fe8f-4af1-8b45-efb1c1b1b83d , 11577/3478043 , 11379/562656 , 11380/1289206 , 11391/1588534 , 11697/207439 , 11585/917519 , 11571/1477361
pmid: 35922517
pmc: PMC9352569
handle: 2117/371635 , 11588/913567 , 1871.1/2b8b46b3-6364-409e-a505-0f32f0f4169b , 11370/00125da7-04c5-43a5-89fb-12f7d70d782f , 2268/294295 , 11365/1220799 , 10807/234173 , 20.500.11820/035ea0f3-fe8f-4af1-8b45-efb1c1b1b83d , 11577/3478043 , 11379/562656 , 11380/1289206 , 11391/1588534 , 11697/207439 , 11585/917519 , 11571/1477361
The COVID-19 pandemic continues to pose a major public health threat, especially in countries with low vaccination rates. To better understand the biological underpinnings of SARS-CoV-2 infection and COVID-19 severity, we formed the COVID-19 Host Genetics Initiative1. Here we present a genome-wide association study meta-analysis of up to 125,584 cases and over 2.5 million control individuals across 60 studies from 25 countries, adding 11 genome-wide significant loci compared with those previously identified2. Genes at new loci, including SFTPD, MUC5B and ACE2, reveal compelling insights regarding disease susceptibility and severity. Here we present meta-analyses bringing together 60 studies from 25 countries (Fig. 1 and Supplementary Table 1) for three COVID-19-related phenotypes: (1) individuals critically ill with COVID-19 on the basis of requiring respiratory support in hospital or who died as a consequence of the disease (9,376 cases, of which 3,197 are new in this data release, and 1,776,645 control individuals); (2) individuals with moderate or severe COVID-19 defined as those hospitalized due to symptoms associated with the infection (25,027 cases, 11,386 new and 2,836,272 control individuals); and (3) all cases with reported SARS-CoV-2 infection regardless of symptoms (125,584 cases, 76,022 new and 2,575,347 control individuals). Most studies have reported results before the roll out of the COVID-19 vaccination campaign. An overview of the study design is provided in Supplementary Fig. 1. We found a total of 23 genome-wide significant loci (P < 5 × 10−8) of which 20 loci remain significant after correction for multiple testing (P < 1.67 × 10−8) to account for the number of phenotypes examined (Fig. 2, Supplementary Fig. 2 and Supplementary Table 2). We compared the effects of these loci between the previous2 and current analysis and found that only one locus did not replicate (rs72711165). All of the other loci showed the expected increase in statistical significance (Supplementary Fig. 3).
Matters arising from: Mapping the human genetic architecture of COVID-19 Original Article published on 08 July 2021 https://www.nature.com/articles/s41586-021-03767-x
Barcelona Supercomputing Center (BSC) authors: Marta Guindo-Martinez, David Torrents, Josep Maria Mercader
Peer Reviewed
:Informàtica::Aplicacions de la informàtica::Bioinformàtica [Àrees temàtiques de la UPC], Human Genetic, Quantitative Trait Loci, MUC5B PROMOTER POLYMORPHISM, Sciences de la santé humaine, Immunologie & maladie infectieuse, Genome-wide association studies, COVID-19 (Malaltia), whole exam sequencing, Medical Genetics and Genomics, UFSP13-7 Evolution in Action: From Genomes to Ecosystems, COVID-19; genetics, name=General, COVID-19 (Disease), SDG 3 - Good Health and Well-being, Matters Arising, Àrees temàtiques de la UPC::Informàtica::Aplicacions de la informàtica::Bioinformàtica, /dk/atira/pure/subjectarea/asjc/1000, Humans, Immunology & infectious disease, Genetic variation, Human health sciences, Genomes, muc5b promoter polymorphism; Science & Technology - Other Topics, Medicinsk genetik, 1000 Multidisciplinary, covid genetics, COVID-19, Chromosome Mapping, Human Genetics, 10124 Institute of Molecular Life Sciences, Medicinsk genetik och genomik, covid-19, 570 Life sciences; biology, Chromosome Mapping; Human Genetics; Humans; Quantitative Trait Loci; COVID-19, Medical Genetics, Human
:Informàtica::Aplicacions de la informàtica::Bioinformàtica [Àrees temàtiques de la UPC], Human Genetic, Quantitative Trait Loci, MUC5B PROMOTER POLYMORPHISM, Sciences de la santé humaine, Immunologie & maladie infectieuse, Genome-wide association studies, COVID-19 (Malaltia), whole exam sequencing, Medical Genetics and Genomics, UFSP13-7 Evolution in Action: From Genomes to Ecosystems, COVID-19; genetics, name=General, COVID-19 (Disease), SDG 3 - Good Health and Well-being, Matters Arising, Àrees temàtiques de la UPC::Informàtica::Aplicacions de la informàtica::Bioinformàtica, /dk/atira/pure/subjectarea/asjc/1000, Humans, Immunology & infectious disease, Genetic variation, Human health sciences, Genomes, muc5b promoter polymorphism; Science & Technology - Other Topics, Medicinsk genetik, 1000 Multidisciplinary, covid genetics, COVID-19, Chromosome Mapping, Human Genetics, 10124 Institute of Molecular Life Sciences, Medicinsk genetik och genomik, covid-19, 570 Life sciences; biology, Chromosome Mapping; Human Genetics; Humans; Quantitative Trait Loci; COVID-19, Medical Genetics, Human
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 377 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 0.1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 0.01% |
| views | 211 | |
| downloads | 272 |

Views provided by UsageCounts
Downloads provided by UsageCounts